In a large-scale meta-analysis, researchers analyzed the prevalence and incidence of cardiovascular diseases and cardiovascular-related death in patients with severe mental illness and the general...
In the year following a new psychosis diagnosis, the death rate for young people is 24 times higher than for young people without psychosis, according to a new study published online in Schizophrenia...
An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
RP5063, a dopamine serotonin stabilizer, was associated with symptom improvement in adults with acute exacerbation of schizophrenia or schizoaffective disorder.
A study was conducted to determine the accuracy of patient symptom documentation in electronic medical records compared to self-reported symptom questionnaires.